A 45-year-old patient is brought to the emergency department with symptoms of anaphylaxis after a bee sting. The patient presents with hypotension, tachycardia, and difficulty breathing. Which of the following is the first-line treatment for this patient?
Explanation & Rationale
Choice A rationale Inhaled beta-agonists like albuterol are useful for treating bronchospasm associated with anaphylaxis, but they do not address the systemic vascular collapse or the underlying allergic cascade. They act locally on the smooth muscles of the bronchioles to cause bronchodilation. However, they are considered secondary or adjunctive treatments. They cannot stabilize blood pressure or prevent the further release of inflammatory mediators, which is why they are never the first-line therapy. Choice B rationale Intravenous fluids are a critical part of the resuscitation process in anaphylaxis to fill the dilated vascular bed and treat the relative hypovolemia. Normal saline or Lactated Ringer's are typically used. While essential, fluid resuscitation is secondary to the administration of a vasopressor that can reverse the underlying vasodilation. Fluids alone cannot stop the physiological cascade of the allergic reaction or provide the necessary vasoconstriction to rapidly restore blood pressure. Choice C rationale Intramuscular epinephrine is the gold standard and first-line treatment for anaphylaxis. It acts on alpha-1 receptors to cause vasoconstriction, which increases peripheral vascular resistance and blood pressure. It also acts on beta-1 receptors to increase heart rate and contractility, and on beta-2 receptors to cause bronchodilation and inhibit the further release of mediators from mast cells and basophils. Its rapid action across multiple systems makes it the most critical intervention for survival. Choice D rationale Oral antihistamines, such as diphenhydramine, are used in the management of allergic reactions to block the effects of histamine at the receptor level. However, they have a slow onset of action and do not treat the life-threatening symptoms of anaphylaxis like airway obstruction or hypotension. They are considered adjunctive therapy to be given after the patient has been stabilized with epinephrine. They are never appropriate as a standalone first-line treatment for shock.